CPAP vs Oral Appliance for Sleep Apnea: Which Works Better?

Bottom line: CPAP usually wins if the question is, “Which treatment lowers breathing events and oxygen desaturation more?” A custom mandibular advancement oral appliance can still be an effective OSA treatment, particularly in mild-to-moderate disease or when PAP is not tolerated well. The useful comparison is therefore not powerful machine versus weak mouthguard. It is physiological efficacy, actual nightly use, anatomy, disease severity, side effects, and follow-up testing considered together.[1-5]

What are the two treatments actually doing?

CPAP—continuous positive airway pressure—uses pressurized air to splint the upper airway open during sleep.

A mandibular advancement device (MAD) is a custom oral appliance that holds the lower jaw forward to enlarge or stabilize the upper airway.

Both aim to reduce obstructive breathing events.

They do it through different mechanisms, which creates different strengths and tradeoffs.

CPAP is usually more effective at lowering AHI

The most consistent finding across comparative reviews is that CPAP reduces the apnea-hypopnea index (AHI) more than mandibular advancement therapy.[1,2]

A 2026 meta-analysis of randomized trials found higher residual AHI with MAD therapy than with CPAP, favoring CPAP by about 11.8 events per hour on average.[2]

That pooled estimate had very high statistical heterogeneity, so the exact number should not be treated as a universal difference for every patient.

But the direction of the evidence is consistent:

CPAP has the stronger average physiological effect on airway obstruction.

The 2026 overview of 14 systematic reviews reached the same general conclusion, finding stronger CPAP effects on objective respiratory outcomes such as AHI and oxygen-desaturation measures.[1]

Oral appliances still work

The fact that CPAP works better on average does not mean oral appliances are placebo-level treatments.

A 2026 systematic review focused on customized oral appliances in mild-to-moderate OSA found repeated improvements in AHI and, in several trials, improvements in sleepiness, oxygen-desaturation measures and mean oxygen saturation.[3]

A separate 2026 meta-analysis found MADs significantly improved AHI compared with sham or control devices.[2]

Current adult OSA guidance also places oral appliance therapy as a recognized option for mild-to-moderate OSA and as an alternative or adjunct when PAP tolerance or adherence is poor.[5]

So the accurate hierarchy is:

• CPAP is usually more potent physiologically.
• A custom mandibular advancement device is still an evidence-based treatment.
• The right choice depends on more than the average AHI difference.

Efficacy and effectiveness are not the same thing

This distinction explains a lot of apparently contradictory sleep-apnea treatment debates.

Efficacy asks:

How well does the treatment work when it is actually being used?

Real-world effectiveness asks:

How much benefit does the person receive over actual nights and months of use?

A therapy that nearly abolishes respiratory events while worn can produce little benefit on nights it stays in a drawer.

Conversely, a less physiologically powerful treatment can still produce meaningful real-world benefit if it is used consistently.

This is one reason some reviews find smaller differences between CPAP and MADs on patient-centered outcomes such as sleepiness or quality of life than on AHI.[1]

That does not prove the two therapies are physiologically equivalent.

It shows that treatment exposure matters.

Adherence is harder to measure than it sounds

Modern PAP devices can often record hours of use directly.

Oral-appliance adherence has historically been more dependent on self-report, although objective microsensors are increasingly available.

That makes simple claims like “people use oral appliances more” less clean than they sound.

Still, comparative reviews commonly report greater acceptance or adherence with mandibular advancement therapy for some patients, while CPAP intolerance remains a real clinical problem.[1]

The practical implication is not that everyone should start with the easier-looking device.

It is that a treatment someone can actually use matters more than a theoretical best treatment they abandon.

Disease severity changes the decision

CPAP has the broadest ability to control obstructive events across OSA severity.

Oral appliances are most established in mild-to-moderate disease and in people who do not tolerate PAP well.[3,5]

That does not mean a person with severe OSA can never respond to a mandibular advancement device.

It means the consequences of incomplete control become more important as baseline disease burden rises.

When severe desaturation, high event burden, major cardiometabolic risk or dangerous sleepiness is present, the margin for leaving substantial residual OSA is smaller.

That is why treatment selection should not be based on comfort alone.

“My snoring stopped” is not enough follow-up

Both CPAP and oral appliances can reduce snoring.

But snoring is not the same thing as OSA control.

Someone can sound quieter while still having clinically important residual respiratory events.

See Snoring vs Sleep Apnea.

Objective follow-up testing matters because it answers a different question:

Did the treatment actually control sleep-disordered breathing?

This is particularly important with oral appliances because the device is often adjusted gradually and response varies between individuals.

Custom and titratable is not the same as an over-the-counter mouthpiece

The oral-appliance evidence should not be generalized to every device sold online.

The 2026 review specifically supports customized oral appliances in mild-to-moderate OSA.[3]

Current guidance likewise prefers custom-made devices over non-custom devices for effectiveness and adherence.[5]

A professionally fitted mandibular advancement device can be adjusted for jaw advancement, comfort and bite effects.

A generic boil-and-bite snoring device is not automatically equivalent to the devices used in clinical trials.

Oral appliances have dental tradeoffs

Mandibular advancement is not biomechanically neutral.

Long-term use can change tooth position, bite relationships and other dental or skeletal measurements.[4]

These changes can be gradual enough that someone feels fine while their occlusion is shifting.

That is why dental follow-up is part of evidence-based oral-appliance care.

Potential issues can include:

• tooth movement;
• bite changes;
• jaw or muscle discomfort;
• salivation or dry mouth; and
• device wear or fit changes.

This does not make oral appliances unsafe by default.

It means their side-effect profile is different from CPAP's.

CPAP has its own tradeoffs

Common PAP problems can include:

• mask discomfort or leak;
• nasal dryness or congestion;
• pressure intolerance;
• aerophagia;
• noise or bed-partner disruption; and
• difficulty maintaining regular use.

Many of these problems are modifiable through mask changes, humidification, pressure adjustment, troubleshooting and follow-up.

A poor first week with CPAP is therefore not always proof that PAP is impossible for that person.

Likewise, a comfortable oral appliance is not automatically proof that it controls OSA adequately.

What about positional therapy?

For people whose OSA is strongly position-dependent, positional therapy can be part of the decision tree.

A 2025 meta-analysis comparing positional therapy with CPAP and oral appliances found positional therapy was generally less effective than CPAP for overall AHI and oxygenation, although it can be useful in selected positional OSA.[6]

See Sleep Position: OSA and Reflux for the position-specific evidence.

The important point is that OSA treatment is not always a binary CPAP-versus-mouthpiece decision.

What if the main problem is nasal obstruction?

Nasal blockage can make PAP harder to tolerate and can influence sleep-disordered breathing symptoms.

Treating nasal obstruction may improve comfort or PAP adherence, but it should not be assumed to cure pharyngeal airway collapse by itself.

See Nasal Obstruction, Snoring and Sleep Apnea.

What the evidence does not support

Current evidence does not justify claims that:

• oral appliances work as well as CPAP for AHI on average;
• CPAP is always the best real-world treatment for every person;
• a comfortable treatment is automatically an effective treatment;
• any store-bought anti-snoring mouthpiece is equivalent to a custom MAD;
• oral appliances have no long-term dental effects;
• stopping snoring proves OSA is controlled;
• severe OSA can be safely self-managed by choosing whichever device feels easiest; or
• failing one mask or one PAP setup proves all PAP therapy will fail.

A better way to compare them

Instead of asking only “Which is better?”, separate the decision into questions:

1. How severe is the OSA?
2. How much oxygen disturbance or sleepiness is present?
3. How much does each therapy reduce residual disease when used?
4. Will the person actually use it consistently?
5. Are there dental, jaw, nasal or pressure-tolerance issues?
6. Has treatment effectiveness been objectively reassessed?

That framework avoids both extremes: treating CPAP as the only legitimate therapy and treating convenience as more important than disease control.

Bottom line

CPAP remains the strongest average therapy for reducing obstructive respiratory events and improving oxygenation.[1,2]

Custom mandibular advancement devices are also legitimate OSA treatments, particularly for mild-to-moderate disease or when PAP is not tolerated well.[2,3,5]

The most evidence-faithful summary is:

CPAP usually wins on physiological efficacy. Oral appliances can win on practicality for selected patients. The real goal is a treatment that is both used and objectively effective.

Related reading

• Snoring vs Sleep Apnea
• Sleep Apnea vs Insomnia
• Sleep Apnea in Women
• Sleep Position: OSA and Reflux
• Nasal Obstruction, Snoring and Sleep Apnea